Pharmaceutical Research & Manufacturers of America
Executive Summary
VP-State Government Affairs Woodrow Allen will resign at the end of the year "to pursue other interests," PhRMA" announces July 12. Allen will serve as a consultant to PhRMA on state issues after his departure. Allen joined the association in 1976 as regional director of state government affairs and became director of state government affairs in 1981 before his promotion to VP in 1986. Prior to joining PhRMA, Allen served four years in the Maryland House of Delegates
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth